北京招聘

Main Job: Management (planning, controlling, monitoring and reporting) of assigned projects for pharmaceutical projects with focus on CMC, process development and manufacturing activities.
Responsibilities:
?Leads project to achieve goals - timeline, budget, scope.
?Creates, updates, and monitors the project plan (incl. milestones and decision points) together with the team, defines work packages according to project scope (what and when).
?Decides and requests required resources at the responsible decision committees, requests team members from line management.
?Initiates and monitors the generation of regulatory documents by the CMC Technical Regulatory Affairs representative and relevant team members.
?Leads and facilitates project team meetings (incl. issuing of agenda, action items, meeting minutes).
?Leads and/or directs customer interaction and communication during the project phase for the clients or R&D team leader and international project manager and coordinates the flow of information from and to the client.
?Represents the project team by communicating the team’s opinion and proposals to committees and external clients, if necessary supported by the relevant team member.
?Identifies, mitigates and escalates project risks (timelines, budget, scope).
职位要求：
Required Capabilities (Skills, Experience, Competencies)
?Bachelor's degree of Chemistry with 8 years relevant work experience
?Master's or Ph.D. degree of Chemistry with 5 years relevant work experience
?Knowledgeable of project management processes (team and steering structures) and tools;
?Possesses strong know how in the area of developing and manufacturing pharmaceuticals;
?Professional expertise in managing projects;
?Able to energize and motivate a team
?Has excellent leadership and communication skills
?Able to illustrate complex issues and to evaluate them critically as well as to navigate a goal-orientated decision process
?Possesses planning and organizational skills

百济神州是一家立足于科学的全球性生物科技公司，专注于开发创新、可负担的药物，旨在为全球患者改善治疗效果，提高药物可及性。目前公司广泛的药物组合包括40多款临床候选药物。公司通过加强自主研发能力和合作，加速推进多元、创新的药物管线开发。我们致力于在2030年前为全球20多亿人全面改善药物可及性。百济神州在全球五大洲打造了一支超过8,000人的团队。